Instacare - Rapid ART Initiation Among Persons With HIV and Out of Care
NCT04240691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2024-12-05
Summary
This study aims to evaluate two ways to help people re-engage with healthcare. The first is to assess if providing HIV treatment on the first visit (or within 1 week) can help people re-engage with care and ultimately stay in care after 24 and 48 weeks. It will also assess the success of starting treatment immediately by measuring the HIV virus in people's bloodstream after 24 and 48 weeks.
The second part of this study is to assess a new behavioral treatment called 60-Minutes-for-Health which aims to help people identify and overcome barriers to HIV care, to help with motivation maintaining in care, to help cope with negative feelings about HIV, and to help increase self-reliance in seeking healthcare amid other things that are happening in your life.
Conditions
- Hiv
- HIV Infections
Interventions
- BEHAVIORAL
-
60-Minutes-For-Health
Refer to description under Groups
- OTHER
-
Time-and-Attention Control Session
Refer to description under Groups
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of California, San Diego
lead OTHER
Principal Investigators
-
Susan Little, MD · UC San Diego AntiViral Research Center (AVRC)
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-20
- Primary Completion
- 2022-09-01
- Completion
- 2024-04-05
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
NCT00705926 ·Status: COMPLETED ·Phase: PHASE1
-
Strategic Timing of Antiretroviral Treatment
NCT00867048 ·Status: COMPLETED ·Phase: PHASE4
-
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
NCT00608569 ·Status: COMPLETED ·Phase: NA
-
Treatment De-Intensification and Residual HIV-1 in Youth
NCT00867854 ·Status: COMPLETED
-
Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy
NCT00001899 ·Status: COMPLETED
-
When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
NCT00055120 ·Status: COMPLETED ·Phase: PHASE4
-
Rapid Antiretroviral Treatment Initiation With BIC/FTC/TAF in HIV-infected People Who Inject Drugs (PWID)
NCT07004933 ·Status: COMPLETED
-
Analytic Treatment Interruption (ATI) to Assess HIV Cure
NCT02437526 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
NCT06337032 ·Status: RECRUITING ·Phase: PHASE4
-
Structured Treatment Interruption (STI) in Acute/Primary HIV
NCT01293513 ·Status: UNKNOWN ·Phase: NA
-
Raltegravir as Early Therapy in African-Americans Living With HIV Study
NCT00667433 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus
NCT00102934 ·Status: UNKNOWN ·Phase: NA
-
Antiretroviral Speed Access Program
NCT04897243 ·Status: RECRUITING
-
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'
NCT04653194 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
NCT00775606 ·Status: TERMINATED ·Phase: PHASE4
-
INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV
NCT03101592 ·Status: TERMINATED ·Phase: NA
-
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
NCT02656511 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
NCT00100646 ·Status: COMPLETED ·Phase: NA
-
Effects of Intensive cART During Acute/Early HIV Infection
NCT01154673 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test
NCT02190578 ·Status: COMPLETED ·Phase: NA
-
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
NCT06101342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)
NCT04644029 ·Status: TERMINATED ·Phase: PHASE3
-
A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
NCT01697046 ·Status: UNKNOWN ·Phase: PHASE3
-
CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
NCT00966160 ·Status: COMPLETED ·Phase: PHASE3
-
Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
NCT00000891 ·Status: COMPLETED ·Phase: PHASE2